NEW YORK, NY / ACCESSWIRE / October 16, 2017 / U.S. markets rose Friday to close the week in the green as investors appear to be expecting a strong earnings season. The Dow Jones Industrial Average gained 0.13 percent to close at 22,871.72, up 0.47 percent for the week, while the S&P 500 Index increased 0.09 percent to close at 2,553.17, up 0.17 percent for the week. The Nasdaq Composite Index rose 0.22 percent to close at 6,605.80, up 0.24 percent for the week. Earnings for the S&P 500 are expected to increase by 4 percent year-over-year in the third quarter, according to data from S&P Capital IQ.

"People are generally expecting a strong earnings season," said Tom Martin, senior portfolio manager at Globalt, according to CNBC. "The good news is the number of companies currently beating estimates, and the margin by which they are doing so, is running at a clip well above what these same 31 companies have recorded, on average, over the past three years," Raich said in a note to clients.

"The bad news is the rate of 3Q 2017 vs. 3Q 2016 earnings and sales growth has slowed from last quarter, and as more companies report the growth rates will drop more," added Raich.

RDI Initiates Coverage on:

Corcept Therapeutics Inc.
https://rdinvesting.com/news/?ticker=CORT

Orexigen Therapeutics Inc.
https://rdinvesting.com/news/?ticker=OREX

Corcept Therapeutics Inc.'s stock moved 4.07% lower Friday, to close the day at $17.92. The stock recorded a trading volume of 1,573,981 shares, which was above its three months average volume of 1,436,750 shares. In the last year Corcept Therapeutics Inc.'s shares have traded in a range of 6.11 - 20.77. The share price has gained 193.29% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $18.16 is greater than its 200-day moving average of $13.33. Shares of the company are trading at a Price to Earnings ratio of 89.15. Shares of Corcept Therapeutics have gained approximately 146.83 percent year-to-date.

Access RDI's Corcept Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CORT

On Friday, shares in Orexigen Therapeutics Inc. recorded a trading volume of 4,279,101 shares, which was above the three months average volume of 140,502 shares. The stock ended the day 3.89% lower at 1.96. The share price has gained 18.83% from its 52 week low with a 52 week trading range of 1.65 - 5.70. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $2.20 is below its 200-day moving average of $2.69. Shares of Orexigen Therapeutics have gained approximately 12.68 percent year-to-date.

Access RDI's Orexigen Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=OREX

Our Actionable Research on Corcept Therapeutics Inc. (NASDAQ: CORT) and Orexigen Therapeutics Inc. (NASDAQ: OREX) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com